Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Multibionta 50+ Extra capsules and tablets
091000000BBUVA0
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Multibionta solution for infusion 10ml ampoules
0903000P0BCAAAB
|
Multibionta | Intravenous nutrition supplements | Nutrition and Blood | No data available |
|
Multibionta Vitality Multivitamin tablets
091200000BFXBFT
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Multiclix lancets 0.3mm/30gauge
21010900686
|
Multiclix lancets 0.3mm/30gauge | Other Appliances | Appliances | No data available |
|
Multiload Cu250 intrauterine contraceptive device
21040000250
|
Multiload Cu250 intrauterine contraceptive device | Contraceptive Devices | Appliances | No data available |
|
Multiload Cu250 Short intrauterine contraceptive device
21040000255
|
Multiload Cu250 Short intrauterine contraceptive device | Contraceptive Devices | Appliances | No data available |
|
Multinutrient capsules
091200000AAFSFS
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Multiparin 125,000units/5ml solution for injection vials
0208010K0BDACA6
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 25,000units/5ml solution for injection vials
0208010K0BDABA5
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 5,000units/5ml solution for injection vials
0208010K0BDAAA4
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multivitamins Plus Minerals for Vegetarians and Vegans tab
091000000BBKNBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Munalea 150microgram/20microgram tablets
0703010E0BNAAAB
|
Munalea (150mcg/20mcg) | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Munuza 300mg/5ml nebuliser solution 5ml ampoules
0501040U0BHAAAG
|
Munuza | Tobramycin | Infections | No data available |
|
Muscinil 5mg tablets
0409020S0BDAAAE
|
Muscinil | Procyclidine hydrochloride | Central Nervous System | No data available |
|
Muse 125microgram urethral sticks
0704050B0BDABAY
|
Muse | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Myalepta 11.3mg powder for solution for injection vials
0607050A0BBACAC
|
Myalepta | Metreleptin | Endocrine System | No data available |
|
Myalepta 3mg powder for solution for injection vials
0607050A0BBAAAA
|
Myalepta | Metreleptin | Endocrine System | No data available |
|
Myalepta 5.8mg powder for solution for injection vials
0607050A0BBABAB
|
Myalepta | Metreleptin | Endocrine System | No data available |
|
Mycamine 100mg powder for solution for infusion vials
0502040B0BBAAAA
|
Mycamine | Micafungin | Infections | No data available |
|
Mycamine 50mg powder for solution for infusion vials
0502040B0BBABAB
|
Mycamine | Micafungin | Infections | No data available |
|
Mycifor XL 500mg tablets
0501050B0BFAAAE
|
Mycifor | Clarithromycin | Infections | No data available |
|
Mycil Athlete's Foot 1% spray
1310020Y0BFADAJ
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycil ointment
1310020Y0BFABAG
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycil powder
1310020Y0BFACAH
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycophenolate mofetil 100mg/5ml oral suspension
0802010M0AAAGAG
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.